Tirzepatide is a drug used primarily for the treatment of type 2 diabetes and, more recently, for the management of obesity. It is a dual agonist of the GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors. Its action is based on mimicking the body’s natural hormones that help regulate blood sugar, reduce appetite and improve metabolic function.